Drug Research
Vaccines Europe Undertakes Its First Regulatory Evaluation
With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership.
The...
Drug Research
By 2028, Non-Vaccine mRNA Therapy Will Earn $2 Billion
A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA (mRNA)...
Drug Research
Synthetic DNA Is Tailored By AI For Future Medicine...
Researchers at Chalmers University of Technology in Sweden have created synthetic DNA that directs the cellular creation of proteins with the aid of an AI....
Drug Research
At $3.5M Hemgenix From CSL- uniQure The Costliest Medicine
There is a new medicine that has surpassed Bluebird Bio as the costliest in the world.
Hemgenix, a haemophilia B gene therapy developed by CSL Behring...
Drug Research
EMA Develops A Quality Control Group To Aid Drug...
To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices for...
Drug Research
RVAC Medicines and A*STAR to Build Capabilities for mRNA...
RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for...
Drug Research
Merck Invests € 290 Million in U.S. Drug Safety...
Merck, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will significantly...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.